Home Blog Page 172

Blog

Pharma Marketing Blog

Most popular

FDA’s “Crimean Referendum” Putsched Aveed Through the Approval Process

Pharma Guy - March 7, 2014

2014 Edition of The Pharmaguy Social Media Timeline™

Pharma Guy - January 31, 2014

Did Pharma Online Ad Spending Increase 50% in First Half of...

Pharma Guy - October 12, 2012

Public Citizen Tracks “Bad Pharma” Financial Settlements

Pharma Guy - November 12, 2012

Drug Ads & Coupons: Who’s the Decider? The Patient, the Physician,...

Pharma Guy - June 27, 2012

Pfizer, If You Are So Smart, How Come You Were Hacked...

Pharma Guy - July 20, 2011

The Most Interesting Pharma Guy in the World!

Pharma Guy - June 29, 2015

Peter Pitts in a Pickle with Journalists and Catholics

Pharma Guy - March 27, 2009

How to Piss Off KOLs

Pharma Guy - May 31, 2006

DTC & Prescribing: Conventional Wisdom Challenged

Pharma Guy - October 4, 2005

1...171172173...240 Page 172 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026